KALVISTA PHARMACEUTICALS INC (KALV)

US4834971032 - Common Stock

10.78  +0.29 (+2.76%)

After market: 10.78 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-1-31)
2023
(2023-4-30)
2022
(2022-4-30)
2021
(2021-4-30)
2020
(2020-4-30)
Revenue
0.000.000.000.0012.69M
Operating Expenses
123.72M110.87M96.61M57.92M53.22M
Research and Development
84.87M80.28M70.17M41.29M40.19M
Selling, General, and Administrative Expenses
38.85M30.60M26.45M16.64M13.03M
Operating Income
-123.72M-110.87M-96.61M-57.92M-40.53M
Interest Income/Expense
3.80M2.18M150.00K1.95M1.76M
Other Income/Expense
11.63M15.78M14.12M9.73M9.53M
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-108.31M-92.91M-82.34M-46.24M-29.24M
Income Tax
N/A0.000.000.00-120.00K
Net Income
-108.31M-92.91M-82.34M-46.24M-29.12M
EBITDA
-122.93M-110.15M-96.05M-57.38M-40.02M
 
Per Share Data
EPS Diluted Total Ops
-3.15-3.33-3.36-2.42-1.64
Non GAAP EPS
-3.15-3.36-3.36-2.40-1.64
 
Statistics
Profit Margin
N/AN/AN/AN/A-229.47%
Operating Profit Margin
N/AN/AN/AN/A-319.39%

All data in USD

Charts